Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming
Executive Summary
The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.
You may also be interested in...
News We’re Watching: Intuitive Plans da Vinci 5 Launch; Roche’s CGM Plan; ReWalk Rebrands, And More
Medtech Insight's News We're Watching highlights medtech industry developments we are following: Intuitive announced an FDA filing for its da Vinci 5 surgical robot; Roche hits at CGM plans; Abbott launches a new smaller rechargeable deep brain stimulator; CroiValve starts transcatheter tricuspid valve trial; ReWalk rebrands as Lifeward; and more news you may have missed.
CMS Extends Telehealth Coverage For 2023
The Medicare Physician Fee Schedule Final Rule for CY 2023 extended the coverage of telehealth services for 2023.
Abbott’s Next-Generation Spinal Cord Stimulator Gets FDA Nod
The newly approved Proclaim Plus system allows physicians to treat as many as six independent pain sites and choose the lowest-possible effective dose for each site.